Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
salofalk 3g prolonged-release granules
dr. falk pharma gmbh - mesalazine - prolonged-release granules - 3 gram(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
salofalk 1.5g prolonged-release granules
dr. falk pharma gmbh - mesalazine - prolonged-release granules - 1.5 gram(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
salofalk 1g/actuation rectal foam
dr. falk pharma gmbh - mesalazine - rectal foam - 1 gram(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
salofalk 4g/60ml enema
dr. falk pharma gmbh - mesalazine - rectal suspension - 4g/60 millilitre(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
pentasa sachet
pco manufacturing - mesalazine - granules prolonged release - 2 grams - mesalazine - intestinal anti-inflammatory agents, aminosalicylic acid and similar agents - it is indicated for mild to moderate ulcerative colitis
Verenigd Koninkrijk -
Engels -
myHealthbox
asacol 500mg suppositories
warner chilcott uk limited - mesalazine - suppositories - 500mg - aminosalicylic acid and similar agents - for the treatment of mild to moderate acute exacerbations of ulcerative colitis. the suppositories are particularly appropriate in patients with distal disease. for the maintenance of remission of ulcerative colitis.
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
asacolon 500 mg suppositories
tillotts pharma gmbh - mesalazine - suppository - 500 milligram(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
asacolon 1600 mg modified-release tablets
tillotts pharma gmbh - mesalazine - modified-release tablet - 1600 milligram(s) - aminosalicylic acid and similar agents; mesalazine
Ierland -
Engels -
HPRA (Health Products Regulatory Authority)
mezavant xl 1200 mg gastro-resistant, prolonged release tablets
shire pharmaceuticals ireland limited - mesalazine - prolonged-release tablet - 1200 milligram(s) - aminosalicylic acid and similar agents; mesalazine
Australië -
Engels -
Department of Health (Therapeutic Goods Administration)
pentasa mesalazine 1g enema bottle
ferring pharmaceuticals pty ltd - mesalazine, quantity: 1000 mg - enema - excipient ingredients: disodium edetate; sodium acetate; purified water; sodium metabisulfite; hydrochloric acid - for the treatment of ulcerative proctosigmoiditis and/or treatment of left-sided ulcerative colitis.